SCG INVESTORIN PTE. LTD.
Country of registration | Singapore |
Registration number | 202244405G |
Local SIC | |
Incorporation date | 13 Dec 2022 |
Company age | 3 years 5 months |
Official entity type | Exempt Private Limited Company |
No. of officers | 7 |
Contact
138 DEPOT ROAD, #04-02, Singapore 109683
This is the legal entity page of SCG INVESTORIN PTE. LTD.. To access company info, company size, news , key makers’ emails, visit the profile pages above.
- SCG CELL THERAPYView MoreSingaporeEstablished in Singapore, SCG Cell Therapy Pte Ltd (SCG) is a biotech company that leverages regional advantages in Singapore, China, and Germany to cover the entire value chain for drug research, discovery, manufacturing, clinical development, and commercialization. SCG specializes in developing novel immunotherapies for infectious diseases and their associated cancers, including Helicobacter pylori, human papillomavirus, and hepatitis B. The company's pipeline includes T cell therapies, antibodies, and therapeutic vaccines to prevent and cure these infections. SCG collaborates with leading scientists and researchers to bring innovative medical products and technologies to market.
Revenue | < 1m |
Share Capital - Ordinary shares | SGD 1 |
Frequently Asked Questions (FAQ)
- What is the address of SCG INVESTORIN PTE. LTD.?
- Where is SCG INVESTORIN PTE. LTD.'s headquarter?
- What is SCG INVESTORIN PTE. LTD.'s contact number?
- What SCG INVESTORIN PTE. LTD.'s spending power?
- Does SCG INVESTORIN PTE. LTD. have a presence in the domain it operates in?

